The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools
Open accessAbstract
Fc receptors (FcRs) belong to the ITAM-associated receptor family. FcRs control the humoral and innate immunity which are essential for appropriate responses to infections and prevention of chronic inflammation or auto-immune diseases. Following their crosslinking by immune complexes, FcRs play various roles such as modulation of the immune response by released cytokines or of phagocytosis. Here, we review FcR involvement in pathologies leading notably to altered intracellular signaling with functionally relevant consequences to the host, and targeting of Fc receptors as therapeutic approaches. Special emphasis will be given to some FcRs, such as the FcαRI, the FcγRIIA and the FcγRIIIA, which behave like the ancient god Janus depending on the ITAM motif to inhibit or activate immune responses depending on their targeting by monomeric/dimeric immunoglobulins or by immune complexes. This ITAM duality has been recently defined as inhibitory or activating ITAM (ITAMi or ITAMa) which are controlled by Src family kinases. Involvement of various ITAM-bearing FcRs observed during infectious or autoimmune diseases is associated with allelic variants, changes in ligand binding ability responsible for host defense perturbation. During auto-immune diseases such as rheumatoid arthritis, lupus or immune thrombocytopenia, the autoantibodies and immune complexes lead to inflammation through FcR aggregation. We will discuss the role of FcRs in autoimmune diseases, and focus on novel approaches to target FcRs for resolution of antibody-mediated autoimmunity. We will finally also discuss the down-regulation of FcR functionality as a therapeutic approach for autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., & Daëron, M. (2009) · Blood · doi:10.1182/blood-2008-09-179754 · Cited by 1,479
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
Kazatchkine, M. D., & Kaveri, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejmra993360 · Cited by 1,209
Spontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis
Bolland, S., & Ravetch, J. V. (2000) · Immunity · doi:10.1016/s1074-7613(00)00027-3 · Cited by 752
Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis
Camps, M., Rückle, T., Ji, H., Ardissone, V., Rintelen, F., Shaw, J., Ferrandi, C., Chabert, C., Gillieron, C., Françon, B., et al. (2005) · Nature Medicine · doi:10.1038/nm1284 · Cited by 750
Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
Milgrom, H., Fick, R. B., Su, J. Q., Reimann, J. D., Bush, R. K., Watrous, M. L., & Metzger, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412603 · Cited by 704
The three human monocyte subsets: implications for health and disease
Wong, K. L., Yeap, W. H., Tai, J. J. Y., Ong, S. M., Dang, T. M., & Wong, S. C. (2012) · Immunologic Research · doi:10.1007/s12026-012-8297-3 · Cited by 680
Gut microbiota utilize immunoglobulin A for mucosal colonization
Donaldson, G. P., Ladinsky, M. S., Yu, K. B., Sanders, J. G., Yoo, B. B., Chou, W.-C., Conner, M. E., Earl, A. M., Knight, R., Bjorkman, P. J., et al. (2018) · Science · doi:10.1126/science.aaq0926 · Cited by 643
Roles of Fc receptors in autoimmunity
Takai, T. (2002) · Nature Reviews Immunology · doi:10.1038/nri856 · Cited by 626
Mouse and human FcR effector functions
Bruhns, P., & Jönsson, F. (2015) · Immunological Reviews · doi:10.1111/imr.12350 · Cited by 579
Monteiro, R. C., & van de Winkel, J. G. J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141011 · Cited by 531
Self-citationAnti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Type I and type II Fc receptors regulate innate and adaptive immunity
Pincetic, A., Bournazos, S., DiLillo, D. J., Maamary, J., Wang, T. T., Dahan, R., Fiebiger, B.-M., & Ravetch, J. V. (2014) · Nature Immunology · doi:10.1038/ni.2939 · Cited by 514
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways
Štefanová, I., Hemmer, B., Vergelli, M., Martin, R., Biddison, W. E., & Germain, R. N. (2003) · Nature Immunology · doi:10.1038/ni895 · Cited by 465
Fanciulli, M., Norsworthy, P. J., Petretto, E., Dong, R., Harper, L., Kamesh, L., Heward, J. M., Gough, S. C. L., de Smith, A., Blakemore, A. I. F., et al. (2007) · Nature Genetics · doi:10.1038/ng2046 · Cited by 464
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
Vaccaro, C., Zhou, J., Ober, R. J., & Ward, E. S. (2005) · Nature Biotechnology · doi:10.1038/nbt1143 · Cited by 407
Fcα/μ receptor mediates endocytosis of IgM-coated microbes
Shibuya, A., Sakamoto, N., Shimizu, Y., Shibuya, K., Osawa, M., Hiroyama, T., Eyre, H. J., Sutherland, G. R., Endo, Y., Fujita, T., et al. (2000) · Nature Immunology · doi:10.1038/80886 · Cited by 388
Bilgiç Temel, A., Bassorgun, C. I., Akman-Karakaş, A., Alpsoy, E., & Uzun, S. (2017) · Case Reports in Dermatology · doi:10.1159/000452828 · Cited by 363
Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation
Pasquier, B., Launay, P., Kanamaru, Y., Moura, I. C., Pfirsch, S., Ruffié, C., Hénin, D., Benhamou, M., Pretolani, M., Blank, U., et al. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.017 · Cited by 346
Self-citationA genome-wide association study identifies three new risk loci for Kawasaki disease
Japan Kawasaki Disease Genome Consortium, Onouchi, Y., US Kawasaki Disease Genetics Consortium, Ozaki, K., Burns, J. C., Shimizu, C., Terai, M., Hamada, H., Honda, T., Suzuki, H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2220 · Cited by 335
Kyogoku, C., Dijstelbloem, H. M., Tsuchiya, N., Hatta, Y., Kato, H., Yamaguchi, A., Fukazawa, T., Jansen, M. D., Hashimoto, H., van de Winkel, J. G. J., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10257 · Cited by 332
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts
Floto, R. A., Clatworthy, M. R., Heilbronn, K. R., Rosner, D. R., MacAry, P. A., Rankin, A., Lehner, P. J., Ouwehand, W. H., Allen, J. M., Watkins, N. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1288 · Cited by 316
FcγRIIb controls bone marrow plasma cell persistence and apoptosis
Xiang, Z., Cutler, A. J., Brownlie, R. J., Fairfax, K., Lawlor, K. E., Severinson, E., Walker, E. U., Manz, R. A., Tarlinton, D. M., & Smith, K. G. C. (2007) · Nature Immunology · doi:10.1038/ni1440 · Cited by 296
Moura, I. C., Centelles, M. N., Arcos-Fajardo, M., Malheiros, D. M., Collawn, J. F., Cooper, M. D., & Monteiro, R. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.417 · Cited by 293
Self-citationAsano, K., Matsushita, T., Umeno, J., Hosono, N., Takahashi, A., Kawaguchi, T., Matsumoto, T., Matsui, T., Kakuta, Y., Kinouchi, Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.482 · Cited by 276
Restoration of Tolerance in Lupus by Targeted Inhibitory Receptor Expression
McGaha, T. L., Sorrentino, B., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1105160 · Cited by 261
Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells
Siragam, V., Crow, A. R., Brinc, D., Song, S., Freedman, J., & Lazarus, A. H. (2006) · Nature Medicine · doi:10.1038/nm1416 · Cited by 246
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Descours, B., Petitjean, G., López-Zaragoza, J.-L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., et al. (2017) · Nature · doi:10.1038/nature21710 · Cited by 242
FcαRI-positive liver Kupffer cells: Reappraisal of the function of immunoglobulin A in immunity
van Egmond, M., van Garderen, E., van Spriel, A. B., Damen, C. A., van Amersfoort, E. S., van Zandbergen, G., van Hattum, J., Kuiper, J., & van de Winkel, J. G. J. (2000) · Nature Medicine · doi:10.1038/76261 · Cited by 240
Src-family kinases: rheostats of immune cell signaling
LOWELL, C. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.010 · Cited by 240
Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin
Ephrem, A., Misra, N., Hassan, G., Dasgupta, S., Delignat, S., Van Huyen, J.-P. D., Chamat, S., Prost, F., Lacroix-Desmazes, S., Kavery, S. V., et al. (2005) · Clinical and Experimental Medicine · doi:10.1007/s10238-005-0079-y · Cited by 231
Toso, a Cell Surface, Specific Regulator of Fas-Induced Apoptosis in T Cells
Hitoshi, Y., Lorens, J., Kitada, S.-I., Fisher, J., LaBarge, M., Ring, H. Z., Francke, U., Reed, J. C., Kinoshita, S., & Nolan, G. P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80551-8 · Cited by 221
Inhibitory Pathways Triggered by ITIM-Containing Receptors
Bolland, S., & Ravetch, J. V. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60019-x · Cited by 220
Identity of the elusive IgM Fc receptor (FcμR) in humans
Kubagawa, H., Oka, S., Kubagawa, Y., Torii, I., Takayama, E., Kang, D.-W., Gartland, G. L., Bertoli, L. F., Mori, H., Takatsu, H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091107 · Cited by 209
McKenzie, S. E., Taylor, S. M., Malladi, P., Yuhan, H., Cassel, D. L., Chien, P., Schwartz, E., Schreiber, A. D., Surrey, S., & Reilly, M. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4311 · Cited by 208
Sanders, L. A., Feldman, R. G., Voorhorst-Ogink, M. M., de Haas, M., Rijkers, G. T., Capel, P. J., Zegers, B. J., & van de Winkel, J. G. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.73-81.1995 · Cited by 198
Fc receptors are major mediators of antibody based inflammation in autoimmunity
Hogarth, P. M. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00409-0 · Cited by 189
McKenzie, S. E., Taylor, S. M., Malladi, P., et al. (1999) · PubMed · Cited by 184
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
Berthelot, L., Papista, C., Maciel, T. T., Biarnes-Pelicot, M., Tissandie, E., Wang, P. H. M., Tamouza, H., Jamin, A., Bex-Coudrat, J., Gestin, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112005 · Cited by 182
Self-citationTsuboi, N., Asano, K., Lauterbach, M., & Mayadas, T. N. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.013 · Cited by 180
Expression Profile of FcγRIIb on Leukocytes and Its Dysregulation in Systemic Lupus Erythematosus
Su, K., Yang, H., Li, X., Li, X., Gibson, A. W., Cafardi, J. M., Zhou, T., Edberg, J. C., & Kimberly, R. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3272 · Cited by 179
Malbec, O., Fong, D. C., Turner, M., Tybulewicz, V. L. J., Cambier, J. C., Fridman, W. H., & Daëron, M. (1998) · PubMed · Cited by 175
Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes
Chan, V. W. F., Lowell, C. A., & DeFranco, A. L. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70223-4 · Cited by 173
Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins
Ahmed, A. A., Giddens, J. P., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L., & Björkman, P. J. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.006 · Cited by 168
Inhibitory ITAMs as novel regulators of immunity
Blank, U., Launay, P., Benhamou, M., & Monteiro, R. C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00832.x · Cited by 167
Self-citationOf ITIM s, ITAM s, and ITAM is: revisiting immunoglobulin Fc receptor signaling
Getahun, A., & Cambier, J. C. (2015) · Immunological Reviews · doi:10.1111/imr.12336 · Cited by 160
Malbec, O., Fong, D. C., Turner, M., Tybulewicz, V. L. J., Cambier, J. C., Fridman, W. H., & Daëron, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1647 · Cited by 160
Verı́, M.-C., Gorlatov, S. N., Li, H., Burke, S., Johnson, S., Stavenhagen, J. B., Stein, K. E., Bonvini, E., & Koenig, S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02588.x · Cited by 158
da Silva, F. P., Aloulou, M., Skurnik, D., Benhamou, M., Andremont, A., Velasco, I. T., Chiamolera, M., Verbeek, J. S., Launay, P., & Monteiro, R. C. (2007) · Nature Medicine · doi:10.1038/nm1665 · Cited by 155
Self-citationZhang, Z., Shen, K., Lü, W., & Cole, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210028200 · Cited by 150
Gillis, C. M., Gouél‐Cheron, A., Jönsson, F., & Bruhns, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00254 · Cited by 147
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Pennington, L. F., Tarchevskaya, S. S., Brigger, D., Sathiyamoorthy, K., Graham, M., Nadeau, K. C., Eggel, A., & Jardetzky, T. S. (2016) · Nature Communications · doi:10.1038/ncomms11610 · Cited by 134
Ouchida, R., Mori, H., Hase, K., Takatsu, H., Kurosaki, T., Tokuhisa, T., Ohno, H., & Wang, J. O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210706109 · Cited by 129
Abram, C. L., Roberge, G., Pao, L. I., Neel, B. G., & Lowell, C. A. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.018 · Cited by 128
Amelioration of Experimental Autoimmune Myasthenia Gravis in Rats by Neonatal FcR Blockade
Liu, L., Garcia, A. M., Santoro, H., Zhang, Y., McDonnell, K. A., Dumont, J., & Bitonti, A. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5390 · Cited by 126
Berthelot, L., Robert, T., Vuiblet, V., Tabary, T., Braconnier, A., Dramé, M., Toupance, O., Rieu, P., Monteiro, R. C., & Touré, F. (2015) · Kidney International · doi:10.1038/ki.2015.158 · Cited by 124
Self-citationThe platelet Fc receptor, FcγRIIa
Qiao, J., Al‐Tamimi, M., Baker, R. I., Andrews, R. K., & Gardiner, E. E. (2015) · Immunological Reviews · doi:10.1111/imr.12370 · Cited by 121
Mkaddem, S. B., Murua, A., Flament, H., Beauport, D. T., Bounaix, C., Danelli, L., Launay, P., Benhamou, M., Blank, U., Daugas, É., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00294-0 · Cited by 120
Self-citationT FcRIIIA158F allele is a risk factor for systemic lupus erythematosus
Koene, H. R., Kleijer, M., Swaak, A. J. G., Sullivan, K. E., Bijl, M., Petri, M., Kallenberg, C. G. M., Roos, D., Borne, A. E. G. K. V. D., & de Haas, M. (1998) · Arthritis & Rheumatism · Cited by 119
Tamouza, H., Chemouny, J., Kafkova, L. R., Berthelot, L., Flamant, M., Demion, M., Mesnard, L., Paubelle, É., Walker, F., Julian, B. A., et al. (2012) · Kidney International · doi:10.1038/ki.2012.192 · Cited by 113
Self-citationAbdel‐Mohsen, M., Kuri-Cervantes, L., Grau-Expósito, J., Spivak, A. M., Nell, R. A., Tomescu, C., Vadrevu, S. K., Giron, L. B., Serra‐Peinado, C., Genescà, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar6759 · Cited by 113
Phenotypic Variation in IgG Receptors by Nonclassical FCGR2C Alleles
van der Heijden, J., Breunis, W. B., Geissler, J., de Boer, M., van den Berg, T. K., & Kuijpers, T. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003945 · Cited by 110
Getahun, A., Beavers, N. A., Larson, S. R., Shlomchik, M. J., & Cambier, J. C. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20150537 · Cited by 106
Fcγ receptors: genetic variation, function, and disease
Hargreaves, C. E., Rose-Zerilli, M. J. J., Machado, L. R., Iriyama, C., Hollox, E. J., Cragg, M. S., & Strefford, J. C. (2015) · Immunological Reviews · doi:10.1111/imr.12341 · Cited by 105
Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura
Carcao, M. D., Blanchette, V. S., Wakefield, C. D., Stephens, D., Ellis, J., Matheson, K. A., & Denomme, G. A. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04033.x · Cited by 105
Iborra, S., Martínez‐López, M., Cueto, F. J., Conde‐Garrosa, R., Fresno, C. D., Izquierdo, H. M., Abram, C. L., Mori, D., Campos‐Martín, Y., Reguera, R. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.012 · Cited by 101
Vuong, M. T., Hahn‐Zoric, M., Lundberg, S. G. G., Gunnarsson, I., van Kooten, C., Wramner, L., Seddighzadeh, M., Fernström, A., Hanson, L. Å., Lieu, T. D., et al. (2010) · Kidney International · doi:10.1038/ki.2010.314 · Cited by 97
Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
Mkaddem, S. B., Hayem, G., Jönsson, F., Rossato, E., Boedec, E., Boussetta, T., Benna, J. E., Launay, P., Goujon, J., Benhamou, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74572 · Cited by 97
Self-citationLaunay, P., Patry, C., Lehuen, A., Pasquier, B., Blank, U., & Monteiro, R. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7216 · Cited by 96
Self-citationKanamaru, Y., Pfirsch, S., Aloulou, M., Vrtovsnik, F., Essig, M., Loirat, C., Deschênes, G., Guérin-Marchand, C., Blank, U., & Monteiro, R. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2669 · Cited by 95
Self-citationSecretory IgA Induces Tolerogenic Dendritic Cells through SIGNR1 Dampening Autoimmunity in Mice
Diana, J., Moura, I. C., Vaugier, C., Gestin, A., Tissandié, E., Beaudoin, L., Corthésy, B., Hocini, H., Lehuen, A., & Monteiro, R. C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300864 · Cited by 93
Self-citationIgG1 and IVIg induce inhibitory ITAM signaling through FcγRIII controlling inflammatory responses
Aloulou, M., Mkaddem, S. B., Biarnes‐Pelicot, M., Boussetta, T., Souchet, H., Rossato, E., Benhamou, M., Crestani, B., Zhu, Z., Blank, U., et al. (2012) · Blood · doi:10.1182/blood-2011-08-376046 · Cited by 92
Self-citationKelley, J. M., Monach, P. A., Ji, C., Zhou, Y., Wu, J., Tanaka, S., Mahr, A., Johnson, S. P., McAlear, C. A., Cuthbertson, D. D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109227109 · Cited by 90
Pfirsch, S., Aloulou, M., Xu, T., Claver, J., Kanamaru, Y., Tiwari, M. K., Launay, P., Monteiro, R. C., & Blank, U. (2011) · Science Signaling · doi:10.1126/scisignal.2001309 · Cited by 89
Self-citationIgG receptor IIa alleles determine susceptibility and severity of Guillain-Barré syndrome
van der Pol, W. L., van den Berg, L. H., Scheepers, R. H. M., van der Bom, J. G., van Doorn, P. A., van Koningsveld, R., van den Broek, M. C. L., Wokke, J. H. J., & van de Winkel, J. G. J. (2000) · Neurology · doi:10.1212/wnl.54.8.1661 · Cited by 86
Jones, M. L., Craik, J. D., Gibbins, J. M., & Poole, A. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402970200 · Cited by 85
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir
Badía, R., Ballana, E., Castellví, M., García-Vidal, E., Pujantell, M., Clotet, B., Prado, J. G., Puig, J., Martínez, M. Á., Riveira‐Muñoz, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05157-w · Cited by 84
Espéli, M., Smith, K. G. C., & Clatworthy, M. R. (2015) · Immunological Reviews · doi:10.1111/imr.12368 · Cited by 83
Tsang-A-Sjoe, M. W. P., Nagelkerke, S. Q., Bultink, I. E. M., Geissler, J., Tanck, M. W. T., Tacke, C. E. A., Ellis, J. A., Zenz, W., Bijl, M., Berden, J. H. M., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kev433 · Cited by 83
Hasegawa, M., Nishiyama, C., Nishiyama, M., Akizawa, Y., Mitsuishi, K., Ito, T., Kawada, H., Furukawa, S., Ra, C., Okumura, K., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1927 · Cited by 80
Sardjono, C. T., Mottram, P. L., van de Velde, N. C., Powell, M. S., Power, D. A., Slocombe, R. F., Wicks, I. P., Campbell, I. K., McKenzie, S. E., Brooks, M., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21344 · Cited by 80
Moroi, R., Endo, K., Kinouchi, Y., Shiga, H., Kakuta, Y., Kuroha, M., Kanazawa, Y., Shimodaira, Y., Horiuchi, T., Takahashi, S., et al. (2013) · Immunogenetics · doi:10.1007/s00251-013-0679-8 · Cited by 79
Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia
Coulon, S., Dussiot, M., Grapton, D., Maciel, T. T., Wang, P. H. M., Callens, C., Tiwari, M. K., Agarwal, S., Fricot, A., Vandekerckhove, J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2462 · Cited by 78
Self-citationMechanisms of Intravenous Immunoglobulin Action in Immune Thrombocytopenic Purpura
Jin, F., & Balthasar, J. P. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.01.029 · Cited by 78
The polymeric immunoglobulin receptor. A model protein to study transcytosis.
Apodaca, G., Bomsel, M., Arden, J. R., Breitfeld, P. P., Tang, K., & Mostov, K. E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115211 · Cited by 77
Silvain, C., Patry, C., Launay, P., Lehuen, A., & Monteiro, R. C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1606 · Cited by 74
Self-citationFc Receptors as Adaptive Immunoreceptors
Daëron, M. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_7 · Cited by 73
Unusual biochemical features and follicular dendritic cell expression of human Fcα/μ receptor
Kikuno, K., Kang, D., Tahara, K., Torii, I., Kubagawa, H. M., Ho, K. J., Baudino, L., Nishizaki, N., Shibuya, A., & Kubagawa, H. (2007) · European Journal of Immunology · doi:10.1002/eji.200737655 · Cited by 67
Zhou, S., Lv, J., Bu, D.-F., Yu, L., Yang, Y.-R., Zhao, J., Cui, Z., Yang, R., Zhao, M., & Zhang, H. (2009) · International Immunology · doi:10.1093/intimm/dxp113 · Cited by 60
Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes
Paul‐Eugène, N., Kolb, J., Abadie, A., Gordon, J. A., Delespesse, G., Sarfati, M., Mencia‐Huerta, J. M., Braquet, P. G., & Dugas, B. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.9.3066 · Cited by 59
IgE Inhibition as a Therapy for Allergic Disease
Jardieu, P. M., & Fick, R. B. (1999) · International Archives of Allergy and Immunology · doi:10.1159/000024043 · Cited by 58
Rossato, E., Mkaddem, S. B., Kanamaru, Y., Hurtado-Nédelec, M., Hayem, G., Descatoire, V., Vonarburg, C., Miescher, S., Zuercher, A. W., & Monteiro, R. C. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39142 · Cited by 57
Self-citationKanamaru, Y., Arcos‐Fajardo, M., Moura, I. C., Tsuge, T., Cohen, H., Essig, M., Vrtovsnik, F., Loirat, C., Peuchmaur, M. M., Beaudoin, L., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200636826 · Cited by 56
Self-citationFcαRI (CD89) Alleles Determine the Proinflammatory Potential of Serum IgA
Wu, J., Ji, C., Xie, F., Langefeld, C. D., Qian, K., Gibson, A., Edberg, J. C., & Kimberly, R. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3973 · Cited by 54
Blocking Fcα Receptor I on Granulocytes Prevents Tissue Damage Induced by IgA Autoantibodies
van der Steen, L. P. E., Bakema, J. E., Sesărman, A., Florea, F., Tuk, C. W., Kirtschig, G., Hage, J. J., Sitaru, C., & van Egmond, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101763 · Cited by 48
Associations Between FCGR3A Polymorphisms and Susceptibility to Rheumatoid Arthritis: A Metaanalysis
Lee, Y. H., Ji, J. D., & Song, G. G. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080186 · Cited by 47
Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer
Hirunsatit, R., Kongruttanachok, N., Shotelersuk, K., Supiyaphun, P., Voravud, N., Sakuntabhai, A., & Mutirangura, A. (2003) · BMC Genetics · doi:10.1186/1471-2156-4-3 · Cited by 45
Human FcR Polymorphism and Disease
Li, X.-R., Gibson, A., & Kimberly, R. (2014) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-07911-0_13 · Cited by 44
Inhibition of destructive autoimmune arthritis in FcγRIIa transgenic mice by small chemical entities
Pietersz, G. A., Mottram, P. L., van de Velde, N. C., Sardjono, C. T., Esparon, S. E., Ramsland, P. A., Moloney, G. M., Baell, J. B., McCarthy, T. D., Matthews, B. R., et al. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.82 · Cited by 44
Recent advances in the physiopathology of IgA nephropathy
Monteiro, R. C. (2018) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2018.02.004 · Cited by 38
Self-citationPecoraro, A., Crescenzi, L., Granata, F., Genovese, A., & Spadaro, G. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.09.005 · Cited by 36
Functional Fcgamma Receptor Polymorphisms Are Associated with Human Allergy
Wu, J., Lin, R., Huang, J.-H., Guan, W., Oetting, W., Sriramarao, P., & Blumenthal, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089196 · Cited by 32
Deglycosylation of FcαR at N58 increases its binding to IgA
Xue, J., Zhao, Q., Zhu, L., & Zhang, W. (2010) · Glycobiology · doi:10.1093/glycob/cwq048 · Cited by 32
FcγRIIB as a Key Determinant of Agonistic Antibody Efficacy
White, A. L., Beers, S. A., & Cragg, M. S. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_16 · Cited by 28
A novel polymorphism of FcαRI (CD89) associated with aggressive periodontitis
Kaneko, S., Kobayashi, T., Yamamoto, K., Jansen, M., van de Winkel, J. G. J., & Yoshie, H. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.0228.x · Cited by 28
Zhou, J., Zhou, Y., Lin, L., Wang, J., Peng, X., Li, J., & Li, L. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.12.001 · Cited by 26
The Old but New IgM Fc Receptor (FcμR)
Kubagawa, H., Kubagawa, Y., Jones, D., Nasti, T. H., Walter, M. R., & Honjo, K. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_1 · Cited by 26
Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice
Honjo, K., Kubagawa, Y., Suzuki, Y., Takagi, M., Ohno, H., Bucy, R. P., Izui, S., & Kubagawa, H. (2014) · International Immunology · doi:10.1093/intimm/dxu070 · Cited by 23
Heineke, M. H., van der Steen, L. P. E., Korthouwer, R., Hage, J. J., Langedijk, J. P. M., Benschop, J. J., Bakema, J. E., Slootstra, J. W., & van Egmond, M. (2017) · European Journal of Immunology · doi:10.1002/eji.201646782 · Cited by 19
The E237G polymorphism of the high-affinity IgE receptor β chain and asthma
Xiaozhu, Z., Zhang, W., Qiu, D., SANDFORD, A. J., & Cheng, T. W. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61419-6 · Cited by 17
Huang, Y., Li, G., An, L., Fan, Y., Cheng, X., Li, X., Yin, Y., Cong, R., Chen, S., & Zhao, S. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.03.032 · Cited by 17
Yang, H., Zheng, L., Zhang, X., Yang, M. H., & Huang, X. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.01.022 · Cited by 13
Cited by
Emerging phagocytosis checkpoints in cancer immunotherapy
Liu, Y., Wang, Y., Yang, Y., Weng, L., Wu, Q., Zhang, J., Zhao, P., Fang, L., Shi, Y., & Wang, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01365-z · Cited by 275
Billingsley, M. M., Gong, N., Mukalel, A. J., Thatte, A. S., El‐Mayta, R., Patel, S. K., Metzloff, A. E., Swingle, K. L., Han, X., Xue, L., et al. (2024) · Small · doi:10.1002/smll.202304378 · Cited by 268
IgA: Structure, Function, and Developability
de Sousa-Pereira, P., & Woof, J. M. (2019) · Antibodies · doi:10.3390/antib8040057 · Cited by 264
Controlling timing and location in vaccines
Irvine, D. J., Aung, A., & Silva, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.019 · Cited by 254
Multifaceted roles of APOE in Alzheimer disease
Jackson, R. J., Hyman, B. T., & Serrano-Pozo, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00988-2 · Cited by 193
Metadata
- Authors
- Ben Mkaddem, S., Benhamou, M., & Monteiro, R. C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-04-12
- Volume
- 10
- Pages
- 811-811
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2936164317
- Cited by
- 283
- References
- 112
- FWCI
- 17.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.